Anhui Sunhere Pharmaceutical Excipients Co Ltd Tangible Net Worth Ratio
Anhui Sunhere Pharmaceutical Excipients Co Ltd tangible net worth ratio. Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) has a Tangible Net Worth Ratio of 95.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥54.64 Million) from net assets (CN¥1.12 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 300452 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Anhui Sunhere Pharmaceutical Excipients Co Ltd (2011–2025)
Tangible net worth ratio of Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2011 to 2025. This chart shows how Anhui Sunhere Pharmaceutical Excipients Co Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 95.1%, reflecting net assets of CN¥1.12 Billion with intangible assets of CN¥54.64 Million CNY. Check 300452 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Tangible Net Worth Ratio by Year (2011–2025)
Anhui Sunhere Pharmaceutical Excipients Co Ltd tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 300452 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | CN¥1.07 Billion | CN¥54.99 Million | CN¥1.71 Billion | ▲ +0.1 pp |
| 2024 | 94.7% | CN¥975.30 Million | CN¥51.22 Million | CN¥1.56 Billion | ▲ +0.3 pp |
| 2023 | 94.4% | CN¥935.25 Million | CN¥52.37 Million | CN¥1.54 Billion | ▲ +1.2 pp |
| 2022 | 93.2% | CN¥788.62 Million | CN¥53.66 Million | CN¥1.18 Billion | ▲ +0.9 pp |
| 2021 | 92.3% | CN¥705.92 Million | CN¥54.48 Million | CN¥962.58 Million | ▼ -2.2 pp |
| 2020 | 94.5% | CN¥655.17 Million | CN¥36.19 Million | CN¥900.87 Million | ▲ +0.7 pp |
| 2019 | 93.8% | CN¥596.57 Million | CN¥37.03 Million | CN¥810.17 Million | ▲ +0.6 pp |
| 2018 | 93.2% | CN¥557.89 Million | CN¥37.89 Million | CN¥709.75 Million | ▲ +1.0 pp |
| 2017 | 92.3% | CN¥500.23 Million | CN¥38.75 Million | CN¥666.40 Million | ▼ -1.6 pp |
| 2016 | 93.8% | CN¥402.70 Million | CN¥24.95 Million | CN¥512.85 Million | ▲ +0.8 pp |
| 2015 | 93.0% | CN¥363.20 Million | CN¥25.52 Million | CN¥458.06 Million | ▲ +7.7 pp |
| 2014 | 85.3% | CN¥177.20 Million | CN¥26.09 Million | CN¥266.39 Million | ▲ +3.1 pp |
| 2013 | 82.1% | CN¥149.23 Million | CN¥26.66 Million | CN¥233.58 Million | ▲ +4.6 pp |
| 2012 | 77.5% | CN¥121.17 Million | CN¥27.23 Million | CN¥212.20 Million | ▲ +6.4 pp |
| 2011 | 71.1% | CN¥95.96 Million | CN¥27.70 Million | CN¥121.51 Million | — |